Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Imedikel Pharma Holding Berhad operates as a Malaysian pharmaceutical holding company with over three decades of experience in pharmacy retailing and contract manufacturing. The company produces food supplements, vitamins, herbal/traditional medicines, cosmetics/cosmeceuticals, health drinks/foodceuticals, and medical devices. It holds GMP certification and Halal OEM recognition from Jakim. Its business model includes both its own brands and extensive OEM/private label manufacturing for third parties in Malaysia—especially Kelantan/Terengganu—and supports entrepreneurs launching new health-related products. There are no disclosed clinical trial results or novel therapeutics under development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Imedikel Pharma Holding.